STUDY OF STROKE SEVERITY (NIHSS SCORE) AND SHORT-TERM OUTCOME- A TERTIARY CARE CENTER EXPERIENCE

Main Article Content

Dr. Nipun Saproo
Dr. Roma Singh
Dr. Harshul Patidar

Keywords

Stroke; National Institutes of Health Stroke Scale; NIHSS; prognosis; modified Rankin Scale; functional outcome

Abstract

Background: Stroke remains a leading cause of mortality and long-term disability worldwide. The National Institutes of Health Stroke Scale (NIHSS) is widely used to quantify neurological impairment at presentation, yet its prognostic value in real-world clinical settings requires ongoing validation. This study aimed to evaluate the relationship between admission NIHSS scores and short-term outcomes, including in-hospital mortality, length of stay, and 30-day functional status.


Methods: A prospective observational study was conducted over 6 months in the Department of Neurology/Medicine of a tertiary care teaching hospital. Two hundred consecutive patients with acute stroke (ischemic or hemorrhagic) presenting within 7 days of symptom onset were enrolled. Baseline NIHSS scores were recorded at admission and categorized as mild (0–5), moderate (6–14), or severe (≥15). Primary outcomes included in-hospital mortality, complications, length of stay, and 30-day functional outcome assessed by the modified Rankin Scale (mRS). Logistic regression analysis identified independent predictors of unfavorable outcome (mRS 3–6).


Results: The mean age was 61.8±12.4 years with 62% male predominance. Hypertension (71%) and diabetes mellitus (39%) were the most prevalent risk factors. Ischemic stroke accounted for 76% of cases. The mean baseline NIHSS score was 9.1±5.8. In-hospital mortality increased progressively from 2.9% in mild strokes to 39.1% in severe strokes. At 30 days, favorable functional outcome (mRS 0–2) was achieved in 79.4% of mild, 46.5% of moderate, and only 13.0% of severe stroke patients. Multivariate analysis revealed that each one-point increase in baseline NIHSS independently raised the odds of unfavorable 30-day outcome by 15% (adjusted OR 1.15, 95% CI 1.08–1.23, p<0.001). Hemorrhagic stroke (adjusted OR 2.05, 95% CI 1.02–4.10, p=0.044) and advancing age (adjusted OR 1.28 per decade, 95% CI 1.06–1.55, p=0.009) were also independent predictors of poor outcome.


Conclusion: Baseline NIHSS score is a powerful, independent predictor of both acute in-hospital outcomes and 30-day functional recovery following stroke. A clear dose-response relationship exists between initial stroke severity and mortality, with each one-point NIHSS increase conferring 15% higher odds of unfavorable outcome. These findings support the systematic use of NIHSS for clinical triaging, resource allocation, prognostication, and family counseling. The high prevalence of delayed hospital presentation (only 27% within 3 hours) underscores the urgent need for enhanced public awareness and primary prevention strategies.

Abstract 0 | Pdf Downloads 0

References

1. Kelly DM, Feld J, Rothwell PM, Reinecke H, Koeppe J. Admission Rates, Time Trends, Risk Factors, and Outcomes of Ischemic and Hemorrhagic Stroke From German Nationwide Data. Neurology. 2022;99(22):e2439-e2451.
2. Lyden P. Using the National Institutes of Health Stroke Scale. Stroke. 2017;48(2):513-519.
3. Olavarría VV, Delgado I, Hoppe A, Brunser A, Cárcamo D, Díaz-Tapia V, et al. Validity of the NIHSS in predicting arterial occlusion in cerebral infarction is time-dependent. Neurology. 2011;76(1):62-68.
4. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53(1):126-131.
5. Wouters A, Nysten C, Thijs V, Lemmens R. Prediction of Outcome in Patients With Acute Ischemic Stroke Based on Initial Severity and Improvement in the First 24 h. Frontiers in Neurology. 2018;9:308.
6. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091-1096.
7. Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections? J Stroke. 2023 Jan;25(1):26-38. doi: 10.5853/jos.2022.02306. Epub 2023 Jan 3. PMID: 36592968; PMCID: PMC9911852.
8. Sussman ES, Connolly ES Jr. Hemorrhagic Transformation: A Review of the Rate of Hemorrhage in the Major Clinical Trials of Acute Ischemic Stroke. Frontiers in Neurology. 2013;4:69.